IP Library › Assignment 072675/0256
Patent Assignment
Reel/Frame 072675/0256

Assignment of Assignor's Interest

Recorded: 2025-08-28 Pages: 5
Assignor
EYEPOINT PHARMACEUTICALS US, INC.
Executed: 2025-08-21
Assignee
EYEPOINT PHARMACEUTICAL, INC.
480 PLEASANT STREET, C400, WATERTOWN, MASSACHUSETTS, 02472
Covered Property (1)
Bioerodible Ocular Drug Delivery Insert and Therapeutic Method
Application: 17/671,060 →
Publication: US 2022/0168142
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 21, 2022
From: SAIM, SAID; HOWARD-SPARKS, MICHELLE; PAGGIARINO, DARIO; KARZOUN, BASEL
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 061165/0912 →
Assignment of Assignor's Interest Aug 28, 2025
From: CHEN, JIANBING
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 072675/0223 →
Merger and Change of Name Aug 28, 2025
From: PSIVIDA INC.; CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 072675/0235 →
Change of Name Aug 28, 2025
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 072675/0250 →
Change of Name Aug 28, 2025
From: PSIVIDA US, INC.
To: EYEPOINT PHARMACEUTICALS US, INC.
Reel/Frame 073067/0650 →
Change of Name Jul 1, 2026
From: EYEPOINT PHARMACEUTICALS, INC.
To: EYEPOINT, INC.
Reel/Frame 075945/0459 →